JP2023546383A - アネキシンａ５組成物及び方法 - Google Patents
アネキシンａ５組成物及び方法 Download PDFInfo
- Publication number
- JP2023546383A JP2023546383A JP2023521687A JP2023521687A JP2023546383A JP 2023546383 A JP2023546383 A JP 2023546383A JP 2023521687 A JP2023521687 A JP 2023521687A JP 2023521687 A JP2023521687 A JP 2023521687A JP 2023546383 A JP2023546383 A JP 2023546383A
- Authority
- JP
- Japan
- Prior art keywords
- annexin
- ace2
- amino acid
- seq
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4721—Lipocortins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Marine Sciences & Fisheries (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063089584P | 2020-10-09 | 2020-10-09 | |
| US63/089,584 | 2020-10-09 | ||
| PCT/CA2021/051422 WO2022073134A1 (en) | 2020-10-09 | 2021-10-08 | Annexin a5 compositions and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023546383A true JP2023546383A (ja) | 2023-11-02 |
| JP2023546383A5 JP2023546383A5 (https=) | 2024-10-17 |
Family
ID=81126326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023521687A Pending JP2023546383A (ja) | 2020-10-09 | 2021-10-08 | アネキシンａ５組成物及び方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20230374091A1 (https=) |
| JP (1) | JP2023546383A (https=) |
| CA (1) | CA3198378A1 (https=) |
| WO (1) | WO2022073134A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025129329A1 (en) * | 2023-12-23 | 2025-06-26 | London Health Sciences Centre Research Inc. | Methods for treatment of sepsis |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012505837A (ja) * | 2008-10-17 | 2012-03-08 | ロンドン ヘルス サイエンシーズ センター リサーチ インコーポレイテッド | 炎症性障害の処置を処置するためのアネキシンおよびその使用 |
| WO2022008654A1 (en) * | 2020-07-09 | 2022-01-13 | Exo Biologics Sa | Process for the manufacturing of protein-associated extracellular vesicles |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002080754A2 (en) * | 2001-04-03 | 2002-10-17 | Theseus Imaging Corporation | Methods for using annexin for detecting cell death in vivo and treating associated conditions |
| DE10145254A1 (de) * | 2001-09-13 | 2003-04-10 | November Ag Molekulare Medizin | Verwendung eines Proteins zur Herstellung eines Medikaments zur Stimulierung einer inflammatorischen zellulären Immunantwort |
| US7452965B2 (en) * | 2002-04-05 | 2008-11-18 | University Of Utah Research Foundation | Colon tumor specific binding peptides |
-
2021
- 2021-10-08 JP JP2023521687A patent/JP2023546383A/ja active Pending
- 2021-10-08 US US18/031,063 patent/US20230374091A1/en active Pending
- 2021-10-08 CA CA3198378A patent/CA3198378A1/en active Pending
- 2021-10-08 WO PCT/CA2021/051422 patent/WO2022073134A1/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012505837A (ja) * | 2008-10-17 | 2012-03-08 | ロンドン ヘルス サイエンシーズ センター リサーチ インコーポレイテッド | 炎症性障害の処置を処置するためのアネキシンおよびその使用 |
| WO2022008654A1 (en) * | 2020-07-09 | 2022-01-13 | Exo Biologics Sa | Process for the manufacturing of protein-associated extracellular vesicles |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022073134A1 (en) | 2022-04-14 |
| CA3198378A1 (en) | 2022-04-14 |
| US20230374091A1 (en) | 2023-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2858661B1 (en) | Stabilized antiviral fusion helices | |
| CN103052647A (zh) | 抗病毒剂 | |
| EA017957B1 (ru) | Композиции и способы, ингибирующие грипп | |
| AU2021228098A1 (en) | Soluble ACE2 and fusion protein, and applications thereof | |
| US11364276B2 (en) | Antiviral peptides for treatment of the middle east respiratory syndrome | |
| CN116209672A (zh) | Sars-cov-2抑制剂 | |
| JP2023546383A (ja) | アネキシンａ５組成物及び方法 | |
| US11299518B2 (en) | Fusion respiratory syncytial virus inhibitors and use thereof | |
| CN113993884A (zh) | 抑制呼吸道合胞病毒感染的生物及合成分子 | |
| US20090312252A1 (en) | Antimicrobial Activity in Variants of Lacritin | |
| US20240002437A1 (en) | Compositions and methods of treating inflammatory lung diseases | |
| WO2022221920A1 (en) | Novel compositions and methods for treating coronavirus infections | |
| Wang et al. | Characterisation and evaluation of antiviral recombinant peptides based on the heptad repeat regions of NDV and IBV fusion glycoproteins | |
| CN113150107A (zh) | 一种白细胞介素29突变体蛋白 | |
| CN117120459A (zh) | 抗感染双环肽配体 | |
| WO2010043046A1 (en) | Peptide inhibitors of type iii secretion | |
| US20250352614A1 (en) | Peptide therapeutics for the treatment of cancer and uses thereof | |
| JP7741108B2 (ja) | インターロイキン２９変異体タンパク質 | |
| US11834480B2 (en) | Protein inhibitors with reduced immunogenicity and resistance to degradation, and methods for their preparation and use | |
| RU2837537C1 (ru) | Растворимый апф2, его слитый белок и способы их применения | |
| US12098175B2 (en) | Peptide inhibitors targeting the CXCL12/HMGB1 interaction and uses thereof | |
| JP2023547881A (ja) | 重症急性呼吸器症候群コロナウイルス－２（ＳＡＲＳ－ＣｏＶ２）感染に対するＡＣＥ－２およびＳ１サブユニット模倣物としてのペプチドおよびそのコンジュゲート体 | |
| WO2024050300A2 (en) | Synthetic surfactants for inhibiting coronavirus infection | |
| HK40056363A (en) | Peptide therapeutics for the treatment of cancer and uses thereof | |
| JP7185874B2 (ja) | 抗ウイルス剤としてのラビリントペプチン |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20241008 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20241008 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250909 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20250910 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251205 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260204 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20260427 |